查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1542557

全球細胞治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 133 Pages | 商品交期: 最快1-2個工作天內

價格

全球細胞治療市場需求預計將從2023年的53.2億美元達到近347.2億美元的市場規模，2024-2032年研究期間複合年成長率為23.18%。

細胞療法是一種利用活細胞來治療或預防疾病的醫療方法。這種方法旨在透過將健康細胞引入患者體內來替換或修復受損的細胞、組織或器官。該療法涵蓋多種技術，包括幹細胞療法（利用幹細胞再生受損組織）和過繼性細胞轉移（其中修飾的免疫細胞靶向並摧毀癌細胞）。該療法在許多領域都有應用，包括腫瘤學、血液學和再生醫學。這種療法透過利用人體的再生能力和增強免疫反應，為治療以前無法治癒的疾病和病症帶來了巨大的希望。正在進行的研究和臨床試驗繼續推進細胞治療的開發和應用。

市場動態

由於慢性和退化性疾病的盛行率不斷增加，細胞治療市場正在經歷大幅成長。細胞療法為癌症、心血管疾病和神經系統疾病等傳統療法可能不足的疾病提供了潛在的治療方法。不斷成長的患者群體和對創新治療方案的需求推動了對先進細胞療法的需求。技術進步代表了市場擴張的重大機會。細胞加工、基因編輯和細胞製造技術的創新正在提高細胞療法的功效和安全性。 CRISPR-Cas9 基因編輯和先進的細胞培養方法等技術正在提高治療的精確度和有效性，促進市場成長。個人化醫療的興起也正在影響市場。這種療法可以根據個別患者的情況進行客製化治療，從而提高治療效果並最大限度地減少不良反應。這種個人化方法的趨勢與對客製化醫療保健解決方案的日益關注相一致，為市場成長創造了新的機會。

擴大細胞療法的研發活動可推動創新和市場成長。對臨床試驗的投資、生物技術公司和研究機構之間的合作以及政府對該療法研究的資助正在加速新療法的開發並擴大可治療疾病的範圍。這些治療產品的監管支持和批准進一步促進了市場成長。隨著監管機構提供更清晰的核准和商業化途徑，細胞療法的開發和市場進入變得更加可行，吸引投資並增加先進治療的可用性。然而，高昂的開發和製造成本、複雜的監管要求以及潛在的道德問題可能會限制市場成長。細胞療法的長期功效和安全性挑戰也可能影響廣泛採用和市場接受度。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞治療市場的每個細分市場進行了包容性評估。細胞治療產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

細胞治療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按治療類型

  • 同種異體療法（幹細胞療法（造血幹細胞療法、間質幹細胞療法）、非幹細胞療法（角質形成細胞和纖維母細胞療法、其他）
  • 自體療法（幹細胞療法（骨髓、血液和臍帶源幹細胞、脂肪源細胞等）
  • 非幹細胞療法（T細胞療法（CAR T細胞療法，基於T細胞受體（TCR）），其他

按治療領域

  • 腫瘤學
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 皮膚科
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲細胞治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞治療市場的主要參與者包括諾華公司、吉利德科學公司、百時美施貴寶公司、強生服務公司、JCR Pharmaceuticals Co. Ltd.、JW Therapeutics、Atara Biotherapeutics、Anterogen Co. Ltd.、Medipost、 S.生物醫學。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：細胞治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按治療類型分類的市場吸引力分析
    • 按治療領域分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球細胞治療市場分析：依治療類型

  • 按治療類型概述
  • 按治療類型進行歷史和預測數據分析
  • 同種異體療法（幹細胞療法（造血幹細胞療法、間質幹細胞療法）、非幹細胞療法（角質形成細胞和纖維母細胞療法、其他）
  • 自體療法（幹細胞療法（骨髓、血液和臍帶源幹細胞、脂肪源細胞等）
  • 非幹細胞療法（T細胞療法（CAR T細胞療法，基於T細胞受體（TCR）），其他

第 6 章：全球細胞治療市場分析：按治療領域

  • 按治療領域概述
  • 按治療領域的歷史和預測數據分析
  • 腫瘤學
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 皮膚科
  • 其他

第 7 章：全球細胞治療市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：細胞治療公司的競爭格局

  • 細胞治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gilead Sciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bristol-Myers Squibb Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Johnson & Johnson Services Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • JCR Pharmaceuticals Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • JW Therapeutics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Atara Biotherapeutics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Anterogen Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Medipost
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • S.Biomedics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11210718

The global demand for Cell Therapy Market is presumed to reach the market size of nearly USD 34.72 Billion by 2032 from USD 5.32 Billion in 2023 with a CAGR of 23.18% under the study period 2024-2032.

Cell therapy is a medical treatment that uses living cells to treat or prevent disease. This approach aims to replace or repair damaged cells, tissues, or organs by introducing healthy cells into a patient's body. This therapy encompasses various techniques, including stem cell therapy, where stem cells are employed to regenerate damaged tissues, and adoptive cell transfer, where modified immune cells target and destroy cancer cells. The therapy has applications across numerous fields, including oncology, hematology, and regenerative medicine. This therapy holds significant promise for treating previously incurable diseases and conditions by harnessing the body's regenerative abilities and enhancing the immune response. Ongoing research & clinical trials continue to advance the development and application of cell-based treatments.

MARKET DYNAMICS

The cell therapy market is experiencing substantial growth attributed to the increasing prevalence of chronic & degenerative diseases. Cell therapy offers potential treatments for conditions such as cancer, cardiovascular diseases, and neurological disorders, where traditional therapies may be insufficient. The growing patient population and the need for innovative treatment options drive demand for advanced cell-based therapies. Technological advancements represent a significant opportunity for market expansion. Innovations in cell processing, gene editing, and cell manufacturing technologies are enhancing the efficacy and safety of cell therapies. Techniques such as CRISPR-Cas9 gene editing and advanced cell culture methods are improving the precision and effectiveness of treatments, fostering market growth. The rise in personalized medicine is also influencing the market. This therapy allows tailored treatments based on individual patient profiles, enhancing treatment outcomes and minimizing adverse effects. This trend towards personalized approaches aligns with the increasing focus on customized healthcare solutions, creating new opportunities for market growth.

Expanding research and development activities in cell therapy drives innovation and market growth. Investment in clinical trials, collaborations between biotech companies and research institutions, and government funding for this therapy research are accelerating the development of new therapies and expanding the range of treatable conditions. Regulatory support and approvals for these therapy products further contribute to market growth. As regulatory agencies provide clearer pathways for approval and commercialization, cell-based therapies' development and market entry become more feasible, attracting investment and increasing the availability of advanced treatments. However, high development and manufacturing costs, complex regulatory requirements, and potential ethical concerns may restrain market growth. Cell therapies' long-term efficacy and safety challenges could also impact widespread adoption and market acceptance.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Therapy. The growth and trends of Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy Type

  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Disease (CVD)
  • Musculoskeletal Disorders
  • Dermatology
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Therapy market include Novartis AG, Gilead Sciences Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, JCR Pharmaceuticals Co. Ltd., JW Therapeutics, Atara Biotherapeutics, Anterogen Co. Ltd., Medipost, S.Biomedics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CELL THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy Type
    • 3.7.2 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL THERAPY MARKET ANALYSIS BY THERAPY TYPE

  • 5.1. Overview By Therapy Type
  • 5.2. Historical and Forecast Data Analysis By Therapy Type
  • 5.3. Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Historic and Forecast Sales By Regions
  • 5.4. Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Historic and Forecast Sales By Regions
  • 5.5. Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Historic and Forecast Sales By Regions

6. GLOBAL CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1. Overview By Therapeutic Area
  • 6.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 6.3. Oncology Historic and Forecast Sales By Regions
  • 6.4. Cardiovascular Disease (CVD) Historic and Forecast Sales By Regions
  • 6.5. Musculoskeletal Disorders Historic and Forecast Sales By Regions
  • 6.6. Dermatology Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CELL THERAPY COMPANIES

  • 8.1. Cell Therapy Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CELL THERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Novartis AG
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Gilead Sciences Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Bristol-Myers Squibb Company
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Johnson & Johnson Services Inc
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. JCR Pharmaceuticals Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. JW Therapeutics
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Atara Biotherapeutics
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Anterogen Co. Ltd.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Medipost
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. S.Biomedics
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Therapy Type (USD MN)
  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Market Sales By Geography (USD MN)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Market Sales By Geography (USD MN)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiovascular Disease (CVD) Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Dermatology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cell Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cell Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Therapy Type
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Therapy Type (USD MN)
  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Market Sales By Geography (USD MN)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Market Sales By Geography (USD MN)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiovascular Disease (CVD) Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Dermatology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.